Germitec Secures €29 Million in Series B Funding for Healthcare Innovation
Deal News | Feb 12, 2025 | Eurazeo
Eurazeo's Nov Sant Actions Non Cotes Fund has completed its third growth equity investment by leading a €29 million Series B fundraising for Germitec, a French MedTech company specializing in innovative high-level disinfection solutions for ultrasound probes. The funding round also saw participation from existing investors like Kurma Partners and Turenne Capital. Germitec, based in Bordeaux, offers chemical-free automatic disinfection devices to significantly lower infection risks in medical settings. With the recent FDA De Novo certification for its Chronos product, Germitec is poised to expand into the U.S. market, capitalizing on the increasing demand for effective healthcare-associated infection prevention. The investment by Eurazeo underscores its commitment to the healthcare sector, supporting innovation and driving the development of European leaders in the field.
Sectors
- Medical Technology (MedTech)
- Private Equity
- Healthcare
Geography
- France – Germitec is a French company and the investment by Eurazeo's fund is part of efforts to strengthen healthcare innovations in France.
- United States – Germitec is planning to expand its market presence in the United States following its FDA certification.
Industry
- Medical Technology (MedTech) – Germitec operates in the MedTech sector, focusing on high-level disinfection solutions for healthcare environments.
- Private Equity – Eurazeo is a private equity firm actively investing in healthcare technology using its Nov Sant Actions Non Cotes Fund.
- Healthcare – Germitec's products address key issues in the healthcare sector, such as infection prevention and disinfection processes.
Financials
- €29 million – The total amount raised in the Series B fundraising round led by Eurazeo for Germitec.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Eurazeo | Lead Investor | Company | A private equity firm that is leading the €29 million Series B fundraising for Germitec. |
| Germitec | Target Company | Company | A French MedTech company specializing in High-Level Disinfection solutions for ultrasound probes. |
| Nov Sant Actions Non Cotes Fund | Investor | Company | A fund managed by Eurazeo, dedicated to developing the healthcare sector in Europe. |
| Kurma Partners | Investor | Company | A health venture subsidiary of Eurazeo participating in the investment round. |
| Financière Arbevel | Investor | Company | An investment firm participating as an existing shareholder in the Series B round. |
| Turenne Capital | Investor | Company | An investment firm participating as an existing shareholder in the Series B round. |